Respiro Diagnostics
RD
RE

Respiro Diagnostics

DR0Ahrefs DR: 0/100. Bottom 25%. Measured by Ahrefs. Median 44.

Developing breath-based diagnostics for lung diseases.

Website
ActiveCambridge, United Kingdom

About

Respiro Diagnostics is a UK-based startup developing a non-invasive liquid biopsy platform that uses exhaled breath to detect lung cancer and other respiratory diseases. Their technology combines a proprietary breath collection device with laboratory methods that analyze DNA, RNA, and proteins captured from breath samples, offering an alternative to invasive tissue biopsies and blood-based liquid biopsies. The platform aims to support earlier diagnosis and provide additional information to guide treatment decisions.

Key facts

At-a-glance profile data

Website
respirox.com
Headquarters
United Kingdom
Total funding
$1M (Pre-Seed)
Business model
B2B

Funding rounds

Funding rounds raised by Respiro Diagnostics
DateRoundAmountLead investors
8 Jul 2026Pre-Seed$1MSFC Capital
Add first review

Frequently asked

How much funding has Respiro Diagnostics raised?

Respiro Diagnostics has raised a total of $1M in funding. The most recent round on record is Pre-Seed.